Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Seagen Inc. - Common Stock
(NQ:
SGEN
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Dec 13, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Seagen Inc. - Common Stock
< Previous
1
2
...
7
8
9
10
11
12
13
14
Next >
Merck/Seagen Potential Deal Talks Pick Up Speed: WSJ
↗
June 24, 2022
Via
Benzinga
Where Seagen Stands With Analysts
↗
June 21, 2022
Analysts have provided the following ratings for Seagen (NASDAQ:SGEN) within the last quarter:
Via
Benzinga
SVB Leerink's Pro-forma Analysis Of Speculated Merck/Seagen Deal - What Investors Need To Know
↗
June 21, 2022
SVB Securities conducted a pro-forma analysis of the financial impact to Merck & Co Inc (NYSE: MRK) from a potential acquisition of Seagen Inc (NASDAQ: SGEN).
Via
Benzinga
SGEN Stock Alert: Is Merck About to Buy Seagen?
↗
June 17, 2022
Today, various reports have highlighted a potential deal for Merck to buy out Seagen, taking SGEN stock on a nice ride this afternoon.
Via
InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
↗
June 17, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Merck Shows Takeover Interest In Seagen: WSJ
↗
June 17, 2022
Via
Benzinga
Amid Domestic Violence Allegation, Longtime Seagen CEO Takes Leave of Absence
↗
May 09, 2022
Via
Benzinga
Seagen CEO Clay Siegall Placed On Leave After Domestic Violence Claim
↗
May 09, 2022
Siegall says he is going through a divorce and denied the claim.
Via
Investor's Business Daily
Expert Ratings for Seagen
↗
April 29, 2022
Within the last quarter, Seagen (NASDAQ:SGEN) has observed the following analyst ratings:
Via
Benzinga
89 Biggest Movers From Friday
↗
June 21, 2022
Gainers Revlon, Inc. (NYSE: REV) jumped 91.3% to close at $3.73 on Friday after the company filed for Chapter 11 bankruptcy.
Via
Benzinga
33 Stocks Moving In Friday's Mid-Day Session
↗
June 17, 2022
Gainers Revlon, Inc. (NYSE: REV) gained 81.5% to $3.54 following a report suggesting Reliance Industries is considering buying out the company, which recently filed for bankruptcy.
Via
Benzinga
Embattled Biotech Seagen Rockets On Rumors Merck Could Buy It
↗
June 17, 2022
The rumor emerges shortly after the company's former CEO was arrested.
Via
Investor's Business Daily
$100 Invested In Seagen 20 Years Ago Would Be Worth This Much Today
↗
June 16, 2022
Seagen (NASDAQ:SGEN) has outperformed the market over the past 20 years by 12.54% on an annualized basis producing an average annual return of 19.38%. Currently, Seagen has a market capitalization of...
Via
Benzinga
HC Wainwright Says This Lymphoma Candidate Has Better Response Rates Than Approved Medications
↗
June 13, 2022
Via
Benzinga
10 Biggest Price Target Changes For Monday
↗
June 06, 2022
Citigroup cut PVH Corp. (NYSE: PVH) price target from $94 to $73. PVH shares fell 0.7% to close at $71.96 on Friday.
Via
Benzinga
5 Growth Stocks to Buy Now
↗
May 27, 2022
EPS estimates are generally a strong indication of future growth. That's just one part of finding reliable growth stocks.
Via
InvestorPlace
Seagen Posts Encouraging Data From Tucatinib Combo Trial In Colorectal Cancer
↗
May 23, 2022
Via
Benzinga
Seagen CEO Clay Siegall Resigns After Domestic Violence Arrest
↗
May 16, 2022
Clay Siegall and the board agreed it would be in investors' best interest if he resigned.
Via
Investor's Business Daily
Large Cap Biopharmaceuticals: Provide Growth, Value And Yield
↗
May 16, 2022
Now that all major biopharmaceutical earnings are in, we can review the financial metrics and see if our portfolio needs re-balancing.
Via
Talk Markets
103 Biggest Movers From Yesterday
↗
May 11, 2022
Gainers
Via
Benzinga
77 Stocks Moving In Tuesday's Mid-Day Session
↗
May 10, 2022
Gainers
Via
Benzinga
Looking Into Seattle Genetics's Return On Capital Employed
↗
May 04, 2022
According to Benzinga Pro data, during Q1, Seattle Genetics (NASDAQ:SGEN) posted sales of $426.46 million. Earnings were up 21.84%, but Seattle Genetics still reported an overall loss of $136.49...
Via
Benzinga
4 Healthcare Funds With "Double Discounts"
↗
April 30, 2022
There's nothing that closed-end fund investors love more than finding a smartly run fund in an unfairly beaten-down sector. This hands us a nice discount plus a much bigger dividend. Let's take a look...
Via
Talk Markets
Read Why This Analyst Is 'Encouraged' By Seagen's Q1 Sales
↗
April 29, 2022
Following Seagen Inc's (NASDAQ: SGEN) 1Q22 earnings release, RBC Capital Markets is encouraged by the quarterly sales of the product portfolio in light of previously set cautious guidance.
Via
Benzinga
Recap: Seagen Q1 Earnings
↗
April 28, 2022
Seagen (NASDAQ:SGEN) reported its Q1 earnings results on Thursday, April 28, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Seagen beat estimated earnings by...
Via
Benzinga
Astellas - Seagen's Padcev Approved In Europe For Most Common Form Of Bladder Cancer
↗
April 13, 2022
The
Via
Benzinga
Seagen Wins $42M Patent Claim Against Daiichi In Cancer Drug Case
↗
April 11, 2022
A jury in Marshall, Texas, awarded Seagen Inc (NASDAQ: SGEN)
Via
Benzinga
Earnings Scheduled For April 28, 2022
↗
April 28, 2022
Companies Reporting Before The Bell • PBF Energy (NYSE:PBF) is projected to report quarterly earnings at $0.26 per share on revenue of $8.24 billion.
Via
Benzinga
Good Entry Point for Biotech Stocks
↗
April 04, 2022
Life science and biotech stocks had a good week with the most well-known ETFs up 3-4% for the week and off recent bottoms.
Via
Talk Markets
Top Nasdaq 100 Stocks: Trading Opportunities For Next Week
↗
April 03, 2022
A security pattern traces the distinct movements of security prices that, once recognized, help traders to make informed trading decisions. Let's look at some Nasdaq 100 stock opportunities by...
Via
Talk Markets
< Previous
1
2
...
7
8
9
10
11
12
13
14
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today